As of May 2022 Adaptive Biotechnologies has a market cap of $1.09 Billion. This makes Adaptive Biotechnologies the world's 4234th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.09 B | -72.31% |
2021 | $3.96 B | -51.03% |
2020 | $8.08 B | 115.83% |
2019 | $3.74 B |
On May 21st, 2022 the market cap of Adaptive Biotechnologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() HCA Healthcare HCA | $60.50 B | 5,418.00% | ๐บ๐ธ USA |
![]() Premier PINC | $4.38 B | 299.83% | ๐บ๐ธ USA |
![]() Community Health Systems
CYH | $0.78 B | -28.76% | ๐บ๐ธ USA |
![]() Select Medical Holdings SEM | $3.17 B | 189.47% | ๐บ๐ธ USA |